ACTINIUM PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 102.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 102.00K shares, a 81.35% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 136.00K shares, a 76.47% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 547.00K shares, a 9439.59% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 578.00K shares, a 91.93% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 285.00K shares, a 94.76% decline from fiscal 2024.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.44M shares, a 24.30% decline from fiscal 2023.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.19M shares, a 39.27% increase from fiscal 2022.
- ACTINIUM PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.16M shares, a 148547.09% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 102.00K shares 10-Q · filed 2026-08-07 | 107.00K shares 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | 136.00K shares 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | 285.00K shares 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | 348.00K shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 547.00K shares 10-Q · filed 2026-08-07 | 547.00K shares 10-Q · filed 2026-08-07 | ||||||
| 2025-03-31 | 578.00K shares 10-Q · filed 2026-05-08 | |||||||
| 2024-12-31 | 5.44M shares 10-K · filed 2026-03-30 | |||||||
| 2024-09-30 | 5.53M shares 10-Q · filed 2025-11-14 | |||||||
| 2024-06-30 | 5.73K shares 10-Q · filed 2024-08-05 | 5.73M shares 10-Q · filed 2025-08-08 | ||||||
| 2024-03-31 | 7.17M shares 10-Q · filed 2025-05-09 | |||||||
| 2023-12-31 | 7.19M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 5.05M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 5.19K shares 10-Q · filed 2024-08-05 | 5.19M shares 10-Q · filed 2023-08-14 | ||||||
| 2023-03-31 | 5.09M shares 10-Q · filed 2024-04-26 | 5.09K shares 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | 5.16M shares 10-K · filed 2024-03-29 | 5.16K shares 10-K · filed 2023-03-31 | ||||||
| 2022-09-30 | 4.93M shares 10-Q · filed 2023-11-02 | 4.93K shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 3.48M shares 10-Q · filed 2023-08-14 | 3.48K shares 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | 3.38K shares 10-Q · filed 2023-05-15 | 3.38M shares 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | 3.47K shares 10-K · filed 2023-03-31 | 3.47M shares 10-K · filed 2022-03-25 | ||||||
| 2021-09-30 | 3.54K shares 10-Q · filed 2022-11-14 | 3.54M shares 10-Q · filed 2021-11-12 | ||||||
| 2021-06-30 | 2.97K shares 10-Q · filed 2022-08-12 | 2.97M shares 10-Q · filed 2021-07-30 | ||||||
| 2021-03-31 | 2.96M shares 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | 2.93M shares 10-K · filed 2022-03-25 | |||||||
| 2020-09-30 | 2.86M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 3.24M shares 10-Q · filed 2021-07-30 | 3.24K shares 10-Q · filed 2020-08-14 | ||||||
| 2020-03-31 | 3.24M shares 10-Q · filed 2021-05-14 | 97.20K shares 10-Q · filed 2020-06-29 | ||||||
| 2019-12-31 | 3.25M shares 10-K · filed 2021-03-31 | 97.53M shares 10-K · filed 2020-05-08 | ||||||
| 2019-09-30 | 3.28M shares 10-Q · filed 2020-10-23 | 98.27M shares 10-Q · filed 2019-11-12 | ||||||
| 2019-06-30 | 3.14K shares 10-Q · filed 2020-08-14 | 94.27M shares 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | 51.26K shares 10-Q · filed 2020-06-29 | 51.26M shares 10-Q · filed 2019-05-10 | ||||||
| 2018-12-31 | 63.06M shares 10-K · filed 2020-05-08 | |||||||
| 2018-09-30 | 63.68M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 61.82M shares 10-Q · filed 2019-08-09 | |||||||
| 2018-03-31 | 61.72M shares 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | 30.84M shares 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | 33.38M shares 10-Q · filed 2018-11-09 | |||||||
| 2017-06-30 | 15.93M shares 10-Q · filed 2018-08-09 | |||||||
| 2017-03-31 | 16.60M shares 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | 14.87M shares 10-K · filed 2019-03-15 | |||||||
| 2016-09-30 | 14.78M shares 10-Q · filed 2017-11-03 | |||||||
| 2016-06-30 | 14.60M shares 10-Q · filed 2017-08-04 | |||||||
| 2016-03-31 | 12.89M shares 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | 12.99M shares 10-K · filed 2018-03-16 | 12.93M shares 10-K · filed 2016-03-11 | ||||||
| 2015-09-30 | 13.24M shares 10-Q · filed 2016-10-28 | |||||||
| 2015-06-30 | 13.75M shares 10-Q · filed 2016-07-29 | |||||||
| 2015-03-31 | 13.44M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 10.71M shares 10-K · filed 2017-03-16 | 10.65M shares 10-K · filed 2015-03-16 | ||||||
| 2014-09-30 | 10.93M shares 10-Q · filed 2015-10-30 | |||||||
| 2014-06-30 | 12.37M shares 10-Q · filed 2015-08-07 | |||||||
| 2014-03-31 | 11.95M shares 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | 11.66M shares 10-K · filed 2016-03-11 | |||||||
| 2013-09-30 | 11.72M shares 10-Q · filed 2014-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |